Autopsy report · NCT01398852
Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia
Cause of deathNo reason given
Life of this trial
- Registered 7 months after it had already started.
- Ran for about 1 year 7 months before it stopped.
- 500 participants enrolled.
- Results were posted on the registry 8 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Topcon Medical Systems, Inc.
- Sponsor type
- Industry
- Conditions
- Keratoconus and Ectasia
- Interventions
- Riboflavin; VEGA UV-A Illumination System
- Participants
- 500
- Sites
- 13
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.